HERMIONE MASTERCLASS HIGH-RISK EARLY STAGE BREAST CANCER: STARTING OF A NEW LEAD GENERATION

1. 1.Zambelli A, Gallerani E, Garrone O, Pedersini R, Rota Caremoli E, Sagrada P, Sala E, Cazzaniga ME.. Working tables on Hormone Receptor positive (HR+), Human Epidermal growth factor Receptor 2 negative (HER2-) early stage breast cancer: Defining high risk of recurrence. Crit Rev Oncol Hematol.. 2023 Nov;191:104104. doi: 10.1016/j.critrevonc.2023.104104. Epub 2023 Sep 1. PMID: 37659765.. 2023
   Articolo scientifico2023 Nov;191:104104. doi: 10.1016/j.critrevonc.2023.104104. Epub 2023 Sep 1. PMID: 37659765.Leggi il PDF gratuito
2. 2.Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P. Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE). J Clin Oncol. 2020 Dec 1;38(34):3987-3998. doi: 10.1200/JCO.20.02514. Epub 2020 Sep 20. PMID: 32954927; PMCID: PMC7768339. 2020
   Articolo scientificoJ Clin Oncol. 2020 Dec 1;38(34):3987-3998. doi: 10.1200/JCO.20.02514. Epub 2020 Sep 20. PMID: 32954927; PMCID: PMC7768339Leggi il PDF gratuito
3. 3.Litton JK, Burstein HJ, Turner NC.. Molecular Testing in Breast Cancer. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e1-e7. doi: 10.1200/EDBK_237715. Epub 2019 May 17. PMID: 31099622.. 2019
   Articolo scientificoAm Soc Clin Oncol Educ Book. 2019 Jan;39:e1-e7. doi: 10.1200/EDBK_237715. Epub 2019 May 17. PMID: 31099622.Leggi il paperCerca versione gratuita

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).